Titre:
  • Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial.
Auteur:Procter, Marion; Suter, Thomas; Azambuja, Evandro; Dafni, U; van Dooren, Veerle; Muehlbauer, Susanne; Climent, Miguel Angel; Rechberger, Ernst; Liu, Walter Tsang-Wu; Toi, Masakazu; Coombes, Raoul Charles; Dodwell, David; Pagani, Olivia; Madrid, Jorge; Hall, Marcia; Chen, Shin-Cheh; Focan, Christian; Muscholl, Michael; van Veldhuisen, Dirk J; Piccart-Gebhart, Martine
Informations sur la publication:Journal of clinical oncology, 28, 21, page (3422-3428)
Statut de publication:Publié, 2010-07
Sujet CREF:Cancérologie
MeSH keywords:Antibodies, Monoclonal -- adverse effects
Antibodies, Monoclonal, Humanized
Antineoplastic Agents -- adverse effects
Breast Neoplasms -- drug therapy
Female
Heart Failure -- chemically induced
Humans
Receptor, erbB-2 -- analysis
Ventricular Function, Left -- drug effects
Note générale:Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2009.26.0463
info:pii/JCO.2009.26.0463
info:pmid/20530280